Investigating how tissue factor contributes to blood clotting issues in COVID-19 patients
Tissue Factor's Role in the Pathogenesis of Hypercoagulability in COVID-19
['FUNDING_R21'] · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · NIH-10580840
This study is looking at how COVID-19 can cause blood clotting problems and aims to find ways to help patients who are experiencing these issues.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TEXAS HLTH CTR AT TYLER (nih funded) |
| Locations | 1 site (TYLER, UNITED STATES) |
| Trial ID | NIH-10580840 on ClinicalTrials.gov |
What this research studies
This research explores the role of tissue factor in causing blood clotting problems in patients with COVID-19. It focuses on understanding how the virus affects blood coagulation and leads to serious complications like thrombosis. The study will examine the mechanisms behind increased tissue factor activity and the release of specific extracellular vesicles in the bloodstream. By investigating these processes, the research aims to identify potential treatments that could reduce clotting issues in affected patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include hospitalized COVID-19 patients experiencing severe coagulopathy or thrombotic complications.
Not a fit: Patients who are not infected with SARS-CoV-2 or those without any coagulation disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve survival rates for critically ill COVID-19 patients by addressing blood clotting complications.
How similar studies have performed: Previous research has indicated that targeting coagulation abnormalities in COVID-19 patients can improve outcomes, suggesting that this approach may be promising.
Where this research is happening
TYLER, UNITED STATES
- UNIVERSITY OF TEXAS HLTH CTR AT TYLER — TYLER, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LELLA, VIJAYA MOHAN RAO — UNIVERSITY OF TEXAS HLTH CTR AT TYLER
- Study coordinator: LELLA, VIJAYA MOHAN RAO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Blood Coagulation Disorders, Coagulation Disorder, bleeding disorder, clotting disorder